Fair value · AMARIN CORP PLC\UK (AMRN) · updated 2026-09-03 · from 20-F FY2025
Everything below is unaffected: the filed statements, the filing they came from, and AMRN’s growth history are all as reported.
20-F FY2025 · fiscal year ended 2025-12-31 · filed 2026-03-02 · accession 0001193125-26-085818
Trailing-twelve-month EPS also uses the quarterly 6-Ks through Q2 FY2026 (filed 2026-07-29).
Open this filing on sec.govAt least two methods need a usable value to draw a range with these inputs.
No preset range for this company yet.
The two ranges are identical because every input sits on a preset.
We don’t tell you what AMRN is worth. Every tab OPENS on what today’s price implies for that method’s key assumption; you decide whether that assumption is reasonable — the growth matrix has AMRN’s filed history and the AI chat will reason it through with you — and the range you build is yours. Our presets are filed history and reference settings, never a recommendation.
Discounted cash flow
N/A
Our price is for one ADS, which represents 20 ordinary shares, but this company files its per-share figures per ordinary share — so these methods need a per-share restatement we do not yet publish.
Preset inputs — revenue-driven DCF from the latest filing
Implied by today’s price
Our price is for one ADS, which represents 20 ordinary shares, but this company files its per-share figures per ordinary share — so these methods need a per-share restatement we do not yet publish.
Not solvable from the price — Our price is for one ADS, which represents 20 ordinary shares, but this company files its per-share figures per ordinary share — so these methods need a per-share restatement we do not yet publish. Showing preset inputs.
This method has no key input to read out of the price. The others below do, and you set them yourself: the growth matrix shows what AMRN has actually filed, and the AI chat will reason it through with you.
Free cash flow grows at your stage-1 rate, then your stage-2 rate, then a terminal rate; everything is discounted at your WACC.
Yearly free-cash-flow growth for the first stage. Starts below zero so a shrinking-cash-flow case — and the rate today’s price implies — can be set.
How long stage-1 growth lasts.
Slower growth after stage 1, before the terminal phase.
Growth forever after the two stages. Above ~3% is rarely justified.
The return you require. Default is the WACC EvidInvest computed for this company. Higher discount rate, lower value.
| Year | Stage | FCF | Present value |
|---|---|---|---|
| 1 | Stage 1 | $7M | $7M |
| 2 | Stage 1 | $8M | $7M |
| 3 | Stage 1 | $8M | $6M |
| 4 | Stage 1 | $9M | $6M |
| 5 | Stage 1 | $9M | $6M |
| 6 | Stage 2 | $9M | $5M |
| 7 | Stage 2 | $9M | $5M |
| 8 | Stage 2 | $10M | $5M |
| 9 | Stage 2 | $10M | $5M |
| 10 | Stage 2 | $10M | $4M |
Inputs from the filing
20-F FY2025 · period ended 2025-12-31 · filed 2026-03-02 · accession 0001193125-26-085818 · sec.gov
Prefer a blank slate with reverse DCF? Open the standalone DCF / reverse DCF for AMRN